Abstract
Background and Aims: Acute kidney injury (AKI) is a frequent complication in hospitalized patients and is diagnosed by urinary output and serum creatinine. For example, up to 20-30% of the patients who undergo elective cardiac surgery develop AKI within 2 days of intervention. Timely diagnosis of AKI should prevent progression into intrinsic and irreversible kidney damage. We here review the clinical utility of AKI biomarkers in the medical laboratory of a tertiary care center.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
